We are investigating the fairness of the proposed sale of Confluent, Inc. (Nasdaq: CFLT) (“Confluent”) to IBM for $31.00 per share in cash.
The sale price is below Confluent’s 52-week high of $37.90 per share, which indicates an opportunistic purchase.
If you remain a Confluent shareholder and have concerns about the fairness of the sale price, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
Why is there an investigation?
On December 8, 2025, Confluent announced that it had agreed to be sold to IBM for $31.00 per share in cash.
The sale price is below Confluent’s 52-week high of $37.90 per share, which indicates an opportunistic purchase.
“We are investigating whether the Confluent Board of Directors acted in the best interests of Confluent shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to Confluent shareholders, as well as whether all material information regarding the transaction has been fully disclosed.”